DATE: Tuesday, April 12, 2016 | TIME: 11am ET / 8am PT | DURATION: 1 Hour

Biotech and Pharma are increasingly using quantitative systems pharmacology modeling (QSPM) approaches to help answer complex, critical Go/No-go decisions in R&D.

Dr. John Burke will discuss the:

  • Value of QSP approaches
  • A QSP industry case study

The case study entails developing and interrogating a QSPM of PD-1 and TIM-3. The QSPM provided:

  • Biological insights by predicting why dosing regimens are quite similar for two therapeutics targeting PD-1 that have affinities that differ by several orders of magnitude
  • Best-in-class profile predictions for PD-1 and TIM-3 dual antagonists

This webinar is ideal for scientists in R&D who want to learn more about how to leverage QSPM to shorten timelines, lower cost, and increase the likelihood of developing best-in-class drugs.


FEATURED SPEAKER:

speaker John M. Burke, PhD — Co-Founder, President, and CEO, Applied BioMath

Prior to co-founding Applied BioMath, Dr. Burke was an Associate Director, Head of Systems Biology at Boehringer Ingelheim where he started, developed and managed the Systems Biology group, portfolio, and strategy. Prior to Boehringer Ingelheim, Dr. Burke was at Merrimack Pharmaceuticals, Co-Scientific Director of the Cell Decision Processes Center, Systems Biology Department, HMS, and was a Sr. Postdoctoral Fellow in Douglas A. Lauffenburger’s lab, Biological Engineering Department, MIT. Dr. Burke holds a PhD degree in Applied Mathematics from Arizona State University.

* by completing this form you acknowledge that you have read and agree to the FierceMarkets Privacy Policy.
*

*

*

*

*

*

*

We never sell or give away your personal info. View privacy policy.

Comments are closed.